NIH-funded research R01 grant

Investigating how a specific potassium channel affects heart function in young patients

Official title: A hERG1 potassium channel subdomain is trafficked to the cardiac nucleus: mechanisms and targets of the hERG1NP

Funded at University of Michigan at Ann Arbor · NIH-10978283 · Data updated 2026-11-12

This study is looking at how a specific protein in the heart, called hERG1, affects young people aged 12-20 and how changes in a related gene might lead to serious heart issues, with the goal of finding ways to help keep their hearts healthy.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startJuly 1, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$477,134
NIH project number1R01HL171039-01A1
Project IDNIH-10978283 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adolescents aged 12-20 who may have genetic variations affecting heart function.

Less likely to help

Patients outside the age range of 12-20 or those without genetic predispositions to cardiac disorders may not benefit from this research.

What this research studies

This research focuses on understanding the role of a potassium channel called hERG1 in the heart, particularly in young patients aged 12-20. It aims to explore how variations in the KCNH2 gene, which encodes hERG1, can lead to serious heart conditions like long QT syndrome and sudden cardiac death. The researchers will use advanced techniques such as molecular biology and confocal microscopy to study how a newly identified protein, hERG1NP, interacts with heart cells and influences their function. By examining these mechanisms, the research seeks to uncover potential targets for improving heart health in adolescents.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and treatment options for heart conditions in young patients.

How similar studies have gone: Previous research has shown promising results in understanding cardiac channelopathies, indicating that this approach could yield valuable insights.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Jones, David K. — University of Michigan at Ann Arbor
  • Study coordinator: Jones, David K.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.